10.1186_1471-2466-11-8.pdf (233.56 kB)

Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial

Download (233.56 kB)
journal contribution
posted on 08.11.2013 by N.C. Thomson, A.S. Rubin, R.M. Niven, P.A. Corris, H.C. Siersted, R. Olivenstein, Ian D. Pavord, D. McCormack, M. Laviolette, N.S. Shargill, G. Cox, the AIR Trial Study Group
Background: Bronchial thermoplasty (BT) is a bronchoscopic procedure that improves asthma control by reducing excess airway smooth muscle. Treated patients have been followed out to 5 years to evaluate long-term safety of this procedure. Methods: Patients enrolled in the Asthma Intervention Research Trial were on inhaled corticosteroids ≥200 μg beclomethasone or equivalent + long-acting-beta2-agonists and demonstrated worsening of asthma on long-acting-β2-agonist withdrawal. Following initial evaluation at 1 year, subjects were invited to participate in a 4 year safety study. Adverse events (AEs) and spirometry data were used to assess long-term safety out to 5 years post-BT. Results: 45 of 52 treated and 24 of 49 control group subjects participated in long-term follow-up of 5 years and 3 years respectively. The rate of respiratory adverse events (AEs/subject) was stable in years 2 to 5 following BT (1.2, 1.3, 1.2, and 1.1, respectively,). There was no increase in hospitalizations or emergency room visits for respiratory symptoms in Years 2, 3, 4, and 5 compared to Year 1. The FVC and FEV[subscript 1] values showed no deterioration over the 5 year period in the BT group. Similar results were obtained for the Control group. Conclusions: The absence of clinical complications (based on AE reporting) and the maintenance of stable lung function (no deterioration of FVC and FEV[subscript 1]) over a 5-year period post-BT in this group of patients with moderate to severe asthma support the long-term safety of the procedure out to 5 years.
Logo branding

Categories

Keyword(s)

History

Citation

BMC Pulmonary Medicine, 2011, 11 : 8

Version

VoR (Version of Record)

Published in

BMC Pulmonary Medicine

Publisher

BioMed Central Ltd

eissn

1471-2466

Copyright date

2011

Available date

08/11/2013

Publisher version

http://www.biomedcentral.com/1471-2466/11/8

Language

en

Exports

Logo branding

Categories

Keyword(s)

Exports